AbbVie Pro website for UK Healthcare Professionals (2023) What is 5 or 2 or 1? https://www.abbviepro.com/gb/en/neuroscience/parkinsons/products/progression-of-pd/what-is-5-or-2-or-1.html. Accessed 3 Jan 2024

Aldred J, Anca-Herschkovitsch M, Antonini A et al (2020) Application of the ‘5-2-1’ screening criteria in advanced Parkinson’s disease: interim analysis of DUOGLOBE. Neurodegener Dis Manag 10:309–323. https://doi.org/10.2217/nmt-2020-0021

Article  PubMed  Google Scholar 

Antonini A, Stoessl AJ, Kleinman LS et al (2018) Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson’s disease: a multi-country Delphi-panel approach. Curr Med Res Opin 34:2063–2073. https://doi.org/10.1080/03007995.2018.1502165

Article  PubMed  Google Scholar 

Antonini A, Odin P, Schmidt P et al (2021) Validation and clinical value of the MANAGE-PD tool: a clinician-reported tool to identify Parkinson’s disease patients inadequately controlled on oral medications. Parkinsonism Relat Disord 92:59–66. https://doi.org/10.1016/j.parkreldis.2021.10.009

Article  CAS  PubMed  Google Scholar 

Armstrong MJ, Okun MS (2020) Diagnosis and treatment of Parkinson Disease: a review. JAMA - J Am Med Assoc 323:548–560. https://doi.org/10.1001/jama.2019.22360

Article  Google Scholar 

Auffret M, Weiss D, Stocchi F et al (2023) Access to device-aided therapies in advanced Parkinson’s disease: navigating clinician biases, patient preference, and prognostic uncertainty. J Neural Transm 130:1411–1432. https://doi.org/10.1007/s00702-023-02668-9

Article  PubMed  Google Scholar 

Ben-Shlomo Y, Darweesh S, Llibre-Guerra J et al (2024) The epidemiology of Parkinson’s disease. Lancet 403:283–292. https://doi.org/10.1016/S0140-6736(23)01419-8

Article  PubMed  Google Scholar 

Bloem BR, Okun MS, Klein C (2021) Parkinson’s disease. Lancet 397:2284–2303. https://doi.org/10.1016/S0140-6736(21)00218-X

Article  CAS  PubMed  Google Scholar 

Borovečki F, Perković R, Kovacs N et al (2023) Are Parkinson’s disease patients referred too late for device-aided therapies and how can better informed and earlier referrals be encouraged? J Neural Transm 130:1405–1409. https://doi.org/10.1007/s00702-023-02680-z

Article  PubMed  Google Scholar 

Bouwmeester W, Zuithoff NPA, Mallett S et al (2012) Reporting and methods in clinical prediction research: a systematic review. PLoS Med 9. https://doi.org/10.1371/journal.pmed.1001221

Bril EV, Tomskiy АA, Poddubskaya AA et al (2021) [Analysing the reasons for rejection of neurosurgery intervention in patients with Parkinson’s disease referred to an extrapyramidal movement disorders clinic]. Ann Clin Exp Neurol 15:43–53 (In Russ.). https://doi.org/10.54101/ACEN.2021.3.5

Article  Google Scholar 

Chaudhuri KR, Batzu L (2023) Can continuous levodopa delivery be achieved in the absence of Intrajejunal Levodopa Infusion? Implications for India and Underserved Countries. Mov Disord Clin Pract 11:21–29. https://doi.org/10.1002/mdc3.13915

Article  PubMed  PubMed Central  Google Scholar 

Collins GS, De Groot JA, Dutton S et al (2014) External validation of multivariable prediction models: a systematic review of methodological conduct and reporting. BMC Med Res Methodol 14:1–11. https://doi.org/10.1186/1471-2288-14-40

Article  Google Scholar 

Collins GS, Reitsma JB, Altman DG, Moons KGM (2015) Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD StatementThe TRIPOD Statement. Ann Intern Med 162:55–63. https://doi.org/10.7326/M14-0697

Article  PubMed  Google Scholar 

Cowley LE, Farewell DM, Maguire S, Kemp AM (2019) Methodological standards for the development and evaluation of clinical prediction rules: a review of the literature. Diagn Progn Res 3:1–23. https://doi.org/10.1186/s41512-019-0060-y

Article  Google Scholar 

Dafsari HS, Silverdale M, Strack M et al (2018) Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson’s disease. Mov Disord 33:421–430. https://doi.org/10.1002/mds.27283

Article  PubMed  Google Scholar 

de Bie RMA, Clarke CE, Espay AJ et al (2020) Initiation of pharmacological therapy in Parkinson’s disease: when, why, and how. Lancet Neurol 19:452–461. https://doi.org/10.1016/S1474-4422(20)30036-3

Article  PubMed  Google Scholar 

de Oliveira LM, Barbosa ER, Aquino CC et al (2019) Deep brain stimulation in patients with mutations in Parkinson’s Disease-related genes: a systematic review. Mov Disord Clin Pract 6:359–368. https://doi.org/10.1002/mdc3.12795

Article  PubMed  PubMed Central  Google Scholar 

Deuschl G, Antonini A, Costa J et al (2022) European Academy of Neurology/Movement Disorder Society-European Section Guideline on the treatment of Parkinson’s Disease: I. Invasive therapies. Mov Disord 37:1360–1374. https://doi.org/10.1002/mds.29066

Article  PubMed  Google Scholar 

Dinkelbach L, Möller B, Witt K et al (2017) How to improve patient education on deep brain stimulation in Parkinson’s disease: the CARE Monitor study. BMC Neurol 17:36. https://doi.org/10.1186/s12883-017-0820-7

Article  PubMed  PubMed Central  Google Scholar 

Dorsey ER, Bloem BR (2018) The Parkinson pandemic - A call to action. JAMA Neurol 75:9–10. https://doi.org/10.1001/jamaneurol.2017.3299

Article  PubMed  Google Scholar 

Dorsey ER, Elbaz A, Nichols E et al (2018) Global, regional, and national burden of Parkinson’s disease, 1990–2016: a systematic analysis for the global burden of Disease Study 2016. Lancet Neurol 17:939–953. https://doi.org/10.1016/S1474-4422(18)30295-3

Article  Google Scholar 

Fabbri M, Barbosa R, Rascol O (2023) Off-time Treatment options for Parkinson’s Disease. Neurol Ther. https://doi.org/10.1007/s40120-022-00435-8

Article  PubMed  PubMed Central  Google Scholar 

Fasano A, Fung VSC, Lopiano L et al (2019) Characterizing advanced Parkinson’s disease: OBSERVE-PD observational study results of 2615 patients. BMC Neurol 19:50. https://doi.org/10.1186/s12883-019-1276-8

Article  PubMed  PubMed Central  Google Scholar 

Fasano A, Fung VSC, Seppi K et al (2022) Intercountry comparisons of advanced Parkinson’s disease symptoms and management: analysis from the OBSERVE-PD observational study. Acta Neurol Scand 146:167–176. https://doi.org/10.1111/ane.13648

Article  PubMed  PubMed Central  Google Scholar 

Foltynie T, Bruno V, Fox S et al (2024) Medical, surgical, and physical treatments for Parkinson’s disease. Lancet (London England) 403:305–324. https://doi.org/10.1016/S0140-6736(23)01429-0

Article  PubMed  Google Scholar 

Geraedts VJ, Kuijf ML, van Hilten JJ et al (2019) Selecting candidates for deep brain stimulation in Parkinson’s disease: the role of patients’ expectations. Park Relat Disord 66:207–211. https://doi.org/10.1016/j.parkreldis.2019.07.011

Article  CAS  Google Scholar 

Gonzalez-Robles C, Bartlett M, Burnell M et al (2023) Embedding patient input in Outcome measures for Long-Term Disease-modifying Parkinson Disease trials. Mov Disord. https://doi.org/10.1002/mds.29691

Article  PubMed  Google Scholar 

Gray R, Patel S, Ives N et al (2022) Long-term effectiveness of adjuvant treatment with Catechol-O-Methyltransferase or monoamine oxidase B inhibitors compared with dopamine agonists among patients with Parkinson Disease uncontrolled by Levodopa Therapy: the PD MED Randomized Clinical Trial. JAMA Neurol 79:131–140. https://doi.org/10.1001/jamaneurol.2021.4736

Article  PubMed  Google Scholar 

Hauser RA, Goud S, Formella AE (2022) Potential utility of amantadine DR/ER in persons with Parkinson’s disease meeting 5-2-1 criteria for device aided therapy. Clin Park Relat Disord 6:100123. https://doi.org/10.1016/j.prdoa.2021.100123

Article  PubMed  Google Scholar 

Henriksen T, Dalhoff KP, Hansen HE et al (2020) Access and Use of device-aided therapies for Parkinson’s Disease in Denmark. Mov Disord Clin Pract 7:656–663. https://doi.org/10.1002/mdc3.12988

Article  PubMed  PubMed Central  Google Scholar 

Jenkinson C, Fitzpatrick R, Peto V et al (1997) The PDQ-8: development and validation of a short-form Parkinson’s disease questionnaire. Psychol Heal 12:805–814. https://doi.org/10.1080/08870449708406741

Article  Google Scholar 

Lange M, Mauerer J, Schlaier J et al (2017) Underutilization of deep brain stimulation for Parkinson’s disease? A survey on possible clinical reasons. Acta Neurochir (Wien) 159. https://doi.org/10.1007/s00701-017-3122-3

Lee TH (1990) Evaluating decision aids: the next painful step [Editorial]. J Gen Intern Med 5:528–529.